This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apixaban
From Proteopedia
(Difference between revisions)
| (7 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='2p16' size='350' side='right' caption='Factor Xa in Complex with the Inhibitor Apixaban' scene='95/953982/Cv/1'> | + | <StructureSection load='2p16' size='350' side='right' caption='Factor Xa in Complex with the Inhibitor Apixaban PDB code [[2p16]].' scene='95/953982/Cv/1'> |
| - | Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting | + | <scene name='95/953982/Cv/3'>Apixaban</scene>, sold under the brand name Eliquis, is an [[Anticoagulants|anticoagulant medication]] used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting [[Factor Xa]]. <scene name='95/953982/Cv/2'>Apixaban binding site</scene>. See also [https://en.wikipedia.org/wiki/Apixaban Apixaban] and [[Rivaroxaban]]. |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Current revision
| |||||||||||
